RNA Regulators in Leukemia and Lymphoma | Zendy

Camila Prieto | Zendy; Michael G. Kharas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

RNA Regulators in Leukemia and Lymphoma

Author(s) -

Camila Prieto,

Michael G. Kharas

Publication year - 2019

Publication title -

cold spring harbor perspectives in medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.853

H-Index - 105

eISSN - 2472-5412

pISSN - 2157-1422

DOI - 10.1101/cshperspect.a034967

Subject(s) - rna binding protein , computational biology , biology , rna , leukemia , messenger rna , regulation of gene expression , genetics , gene

Posttranscriptional regulation of mRNA is a powerful and tightly controlled process in which cells command the integrity, diversity, and abundance of their protein products. RNA-binding proteins (RBPs) are the principal players that control many intermediary steps of posttranscriptional regulation. Recent advances in this field have discovered the importance of RBPs in hematological diseases. Herein we will review a number of RBPs that have been determined to play critical functions in leukemia and lymphoma. Furthermore, we will discuss the potential therapeutic strategies that are currently being studied to specifically target RBPs in these diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research